| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00634517 Details | 2013-07-15 Interventional | 3 | 48 | Albuterol Asthma | IND voluntarily withdrawn, without prejudice - | |||
| NCT00623727 2007-003718-32 Details | 2013-07-15 Interventional | 2 | [2 Refs] | 143 | Factor VIII Hemophilia A | - The recruitment and double-blind study phase were prematurely terminated after a scheduled interim analysis confirmed overt failure regarding the primary endpoint as judged by the independent Data and Safety Monitoring Board. | ||
| NCT01104844 Details | 2013-07-12 Interventional | 2 | 0 | Acetaminophen Ibuprofen Toothache Dental Pain | The study was withdrawn due to administrative reason - | |||
| NCT00054392 Details | 2013-07-11 Interventional | 3 | [5 Refs] | 0 | Carboplatin Gemcitabine Paclitaxel Carcinoma, Non-… Lung Neoplasms Lung Cancer | Not opened at Fox Chase Cancer Center - | ||
| NCT00748527 NCT00514124 2006-002324-41 Details | 2013-07-10 Interventional | 2 | - | Carboplatin Decitabine Carcinoma, Ovar… Fallopian Tube … Ovarian Neoplas… Fallopian Tube … Ovarian Cancer Peritoneal Cavi… | The study was "withdrawn" due to certain adverse events [hypersensitivity]. - | |||
| NCT00674557 2007-005752-16 Details | 2013-07-10 Interventional | 2 | - | Exemestane Tetrathiomolybd… Breast Neoplasm… Breast Cancer | Withdrawn as the clinical development of ATN-224 was terminated by the drug company who was
providing ATN-224 for the study - | |||
| NCT00080613 Details | 2013-07-10 Interventional | 2 | - | Exemestane Hormones Breast Neoplasm… Stage II Breast… Stage IIIA Brea… Stage IIIB Brea… Stage IIIC Brea… | - - | |||
| NCT00072228 Details | 2013-07-10 Interventional | 1 | - | Gemcitabine Soblidotin Neoplasms Unspecified Adu… | - - | |||
| NCT00084448 Details | 2013-07-09 Interventional | 2 | - | Celecoxib Paclitaxel Ovarian Cancer Primary Periton… | - - | |||
| NCT00012194 NCT00227396 Details | 2013-07-09 Interventional | 1 | 30 | 7-hydroxystauro… Neoplasms Unspecified Adu… | - - | |||
| NCT00003378 Details | 2013-07-09 Interventional | 1 | [2 Refs] | - | Carboplatin Gemcitabine Paclitaxel Ovarian Cancer Primary Periton… | - - | ||
| NCT00002993 Details | 2013-07-09 Interventional | 2 | [1 Refs] | - | Doxorubicin Liposomal doxor… Mitomycin Mitomycins Sarcoma | - - | ||
| NCT01193166 Details | 2013-07-08 Interventional | 4 | 0 | Aripiprazole Olanzapine Paliperidone Pa… Perphenazine Quetiapine Fuma… Risperidone Schizophrenia | This study was stopped due to an internal reconsideration of priorities of the product
portfolio. - | |||
| NCT01281943 Details | 2013-07-04 Interventional | 2 | 0 | Doxorubicin Liposomal doxor… MTOR Inhibitors Sirolimus Temsirolimus Carcinoma, Hepa… Liver Neoplasms | Doxil Shortage - | |||
| NCT00961649 Details | 2013-07-04 Interventional | 2 | 195 | Brimonidine Tar… Brinzolamide Ophthalmic Solu… Glaucoma Glaucoma, Open-… Hypertension Ocular Hyperten… Open-Angle Glau… | - - | |||
| NCT01593137 2012-000311-87 Details | 2013-07-02 Interventional | 4 | 0 | Glimepiride Liraglutide Metformin Diabetes Mellit… Diabetes Mellit… Type 2 Diabetes | Lack of patients with the criteria established in the protocol. - | |||
| NCT01320020 Details | 2013-07-02 Interventional | 1 | 16 | Catumaxomab Epithelial Canc… | - - | |||
| NCT01282333 Details | 2013-07-02 Interventional | 1 | 44 | Gemcitabine Veliparib Bile Duct Neopl… Carcinoma, Non-… Carcinoma, Tran… Gallbladder Neo… Kidney Neoplasm… Liver Neoplasms Lung Neoplasms Pancreatic Neop… Ureteral Neopla… Urinary Bladder… Advanced Adult … Localized Unres… Metastatic Tran… Regional Transi… Stage III Bladd… Stage III Pancr… Stage IIIA Non-… Stage IIIB Non-… Stage IV Bladde… Stage IV Non-sm… Stage IV Pancre… Transitional Ce… Unresectable Ex… Unresectable Ga… | - - | |||
| NCT01009879 Details | 2013-07-02 Interventional | 4 | 0 | Etanercept Arthritis Arthritis, Rheu… Rheumatoid Arth… | No subjects were enrolled - | |||
| NCT00906360 Details | 2013-07-02 Interventional | 1 | 36 | Antibodies Antibodies, Mon… Antineoplastic … Cetuximab Immunoglobulins Sunitinib Carcinoma Carcinoma, Squa… Carcinoma, Verr… Head and Neck N… Laryngeal Disea… Laryngeal Neopl… Nasopharyngeal … Neoplasms, Unkn… Oropharyngeal N… Paranasal Sinus… Recurrence Salivary Gland … Squamous Cell C… Tongue Neoplasm… Metastatic Squa… Recurrent Metas… Recurrent Saliv… Recurrent Squam… Recurrent Squam… Recurrent Squam… Recurrent Squam… Recurrent Squam… Recurrent Squam… Recurrent Verru… Recurrent Verru… Salivary Gland … Stage III Saliv… Stage III Squam… Stage III Squam… Stage III Squam… Stage III Squam… Stage III Squam… Stage III Squam… Stage III Verru… Stage III Verru… Stage IV Saliva… Stage IV Squamo… Stage IV Squamo… Stage IV Squamo… Stage IV Squamo… Stage IV Squamo… Stage IV Squamo… Stage IV Verruc… Stage IV Verruc… Tongue Cancer Untreated Metas… | - - |